Actively Recruiting
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Led by Cairo University · Updated on 2024-07-10
70
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
CONDITIONS
Official Title
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy of singleton living fetus
- Previous one or more cesarean sections
- Gestational age: > 32 weeks
- Presence of ultrasound markers such as loss of clear retroplacental translucency, myometrial thinning, abnormal lacunae, irregular bladder wall, or utero-vesical hypervascularity
- Preoperative hemoglobin more than 10 gm/dl
- Cases with Placenta Accreta Spectrum undergoing cesarean hysterectomy
You will not qualify if you...
- Maternal medical disorders such as coagulation defects or cardiac diseases
- Known or reported hypersensitivity to the medications used
- Cases with spontaneous placental separation at laparotomy
- Patients undergoing conservative management of Placenta Accreta Spectrum
- Cases requiring emergency termination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt
Actively Recruiting
Research Team
A
Abdalla Mousa
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here